How Does Lucette Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Lucette Works

  • Active Ingredients: 0.03 mg ethinylestradiol (oestrogen) and 3 mg drospirenone (progestogen).
  • Primary Actions: Prevents ovulation, thickens cervical mucus, alters endometrium.
  • Unique Progestogen: Drospirenone has anti‑androgenic and anti‑mineralocorticoid properties, reducing acne and water retention.
  • Onset & Duration: Immediate if started on day 1 of cycle; otherwise use extra precautions for 7 days. Steady state reached in 10‑14 days.
  • Metabolism: Ethinylestradiol via CYP3A4; drospirenone via lactone ring opening (non‑CYP). Excreted in urine and faeces.

Lucette combines ethinylestradiol and drospirenone to provide reliable contraception through multiple mechanisms. This dual‑action pill not only prevents ovulation but also offers additional benefits such as improved acne control and minimal weight gain due to its unique progestogen profile.

Important Medical Advice

If you experience sudden severe chest pain, breathlessness, persistent leg swelling, severe headache, or visual disturbances, stop taking Lucette and seek immediate medical attention — these could be signs of a blood clot (venous thromboembolism). Always read the PIL and consult your doctor.

Chemical Composition & Molecular Structure

Lucette film‑coated tablets contain two active substances: 0.03 mg ethinylestradiol and 3 mg drospirenone. The tablet core includes lactose monohydrate, maize starch, povidone, and magnesium stearate; the film‑coat contains polyvinyl alcohol, titanium dioxide, talc, macrogol, and soya lecithin.

Structural Details

Ethinylestradiol

19‑nor‑17α‑pregna‑1,3,5(10)‑trien‑20‑yne‑3,17‑diol

A synthetic oestrogen with high potency due to the ethinyl group at C17, which slows hepatic metabolism. It binds to oestrogen receptors (ERα/ERβ) and regulates gene transcription in reproductive tissues.

Drospirenone

6β,7β:15β,16β‑dimethylene‑3‑oxo‑17α‑pregn‑4‑ene‑21,17‑carbolactone

A unique progestogen derived from spironolactone. It possesses anti‑androgenic and anti‑mineralocorticoid activity, closely mimicking natural progesterone. The lactone group contributes to its long half‑life.

Key Pharmaceutical Properties

PropertyEthinylestradiolDrospirenone
Lipophilicity (logP)3.672.2
Protein binding98% (albumin)97% (albumin, not SHBG)
Bioavailability~45% (first‑pass)~76%
Receptor affinityOestrogen receptorProgesterone, androgen, mineralocorticoid receptors

🗒️ Pharmaceutical insight: The lactose content (48.17 mg) is well tolerated by most; however, women with hereditary galactose intolerance should consult their doctor. Soya lecithin may cause allergic reactions in individuals allergic to peanut or soya.

Mechanism of Action: Dual Pathway

Lucette’s contraceptive efficacy relies on three complementary actions:

  1. Ovulation inhibition: Drospirenone suppresses gonadotropin secretion (FSH and LH), preventing follicular maturation and ovulation. Ethinylestradiol reinforces this negative feedback.
  2. Cervical mucus thickening: The progestogen increases mucus viscosity, creating a barrier to sperm penetration.
  3. Endometrial alteration: The endometrium becomes atrophic and unreceptive to implantation.

In addition, drospirenone exhibits anti‑androgenic activity (competitive androgen receptor blockade) and anti‑mineralocorticoid effects (mild diuretic action), which counteract oestrogen‑induced sodium retention and help maintain stable body weight.

FeatureEthinylestradiolDrospirenone
Onset of contraceptive effect7 days of continuous useImmediate if started day 1
Peak serum concentration1‑2 h1‑2 h
Duration of action24 h>30 h (supports 24‑h dosing)

🗒️ Physiological insight: The anti‑mineralocorticoid activity of drospirenone can lead to a slight increase in potassium levels; caution with long‑term use of potassium‑sparing diuretics is advised.

Absorption & Distribution (Pharmacokinetics)

Both components are rapidly absorbed after oral administration. Peak plasma concentrations are reached within 1‑2 hours. Food does not significantly affect absorption.

Distribution

Ethinylestradiol is extensively bound to serum albumin (98%), while drospirenone binds to albumin (97%) but not to sex hormone binding globulin (SHBG). This avoids competition with testosterone. Volume of distribution for both is around 4 L/kg.

Steady state

Steady state for drospirenone is achieved after 10‑14 days of daily administration, with about 2‑ to 3‑fold accumulation due to its long half‑life (30‑34 h). Ethinylestradiol reaches steady state within one week.

Metabolic Effects & Elimination

Ethinylestradiol undergoes extensive first‑pass metabolism in the gut wall and liver, primarily via CYP3A4 hydroxylation. It also forms conjugates (glucuronides and sulphates). The metabolites are excreted in urine and bile, with an elimination half‑life of 12‑24 h.

Drospirenone is metabolised to inactive acid metabolites via lactone ring opening, a process that does not involve cytochrome P450 enzymes. It is eliminated as metabolites with a half‑life of approximately 30‑34 h, mainly in faeces and urine.

⚠️ Metabolic caution: Women with mild to moderate hepatic impairment show reduced drospirenone clearance. Lucette is contraindicated in severe hepatic disease (see section 2 of PIL).

Clinical Efficacy in Contraception

Lucette has a Pearl Index of 0.11‑0.41 in typical use, indicating high contraceptive reliability. It is licensed for women of reproductive age and can be used as long‑term contraception under medical supervision. In addition to pregnancy prevention, many users experience:

  • Improved acne due to anti‑androgenic effects
  • Reduced bloating and stable weight (anti‑mineralocorticoid action)
  • Regular, lighter withdrawal bleeds

Clinical studies show that drospirenone‑containing pills are associated with lower rates of fluid‑retention symptoms compared to other progestogens.

Lucette FAQs

If started on the first day of your period, protection is immediate. If started on days 2‑5, use condoms for the first 7 days. After a pill‑free interval of 7 days, protection continues without gap.

If you are less than 12 h late, take it immediately and continue normally. If more than 12 h late, follow the PIL: take the last missed pill, and use extra precautions for 7 days. See the detailed flowchart in the package leaflet.

Unlike older pills, drospirenone has anti‑mineralocorticoid properties that counteract water retention. Most women do not experience weight gain; some even report a slight decrease. Changes in appetite may occur.

No. Migraine with aura increases the risk of stroke and is a contraindication for all combined hormonal contraceptives. Discuss non‑hormonal options with your doctor.

Yes. Enzyme inducers (e.g., rifampicin, carbamazepine, St John’s wort) reduce efficacy. Some hepatitis C drugs are contraindicated. Always inform your doctor about all medicines you take.

Need Lucette with Expert Guidance?

If you are considering Lucette for contraception, our UK‑registered doctors can assess your suitability and provide a prescription online after a consultation.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start Contraception Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 17 March 2026

Next Review: 17 September 2026

Published on: 17 March 2026

Last Updated: 17 March 2026